CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CPRX on Nasdaq
CUSIP
14888U101
Type / Class
Equity / COMMON STOCK
Shares outstanding
123M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
103M
Holdings value
$2.03B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
352
Number of buys
174
Number of sells
-178
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13.9% $399M 16.9M BlackRock, Inc. Mar 31, 2025
STATE STREET CORP 5.2% $126M 6.41M STATE STREET CORPORATION Sep 30, 2025
Flynn James E 2.63% $74M 3.13M Deerfield Mgmt, L.P. Dec 31, 2024

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 103M $2.03B +$33.5M $19.70 352
2025 Q2 101M $2.2B +$75.1M $21.70 359
2025 Q1 97.9M $2.37B +$45.7M $24.25 364
2024 Q4 97.5M $2.03B +$40.4M $20.87 333
2024 Q3 95.3M $1.89B -$37.3M $19.88 310
2024 Q2 97M $1.5B +$14M $15.49 268
2024 Q1 96.1M $1.53B +$189M $15.94 267
2023 Q4 84.4M $1.42B +$63M $16.81 257
2023 Q3 81.1M $949M -$23.4M $11.69 253
2023 Q2 82.2M $1.1B -$95.3M $13.44 243
2023 Q1 88.8M $1.47B +$71M $16.58 257
2022 Q4 84.1M $1.56B -$12.2M $18.60 252
2022 Q3 85.1M $1.09B +$187M $12.83 222
2022 Q2 75.7M $530M +$37.8M $7.01 176
2022 Q1 70.8M $587M +$41.3M $8.29 182
2021 Q4 66M $447M +$3.69M $6.77 160
2021 Q3 65.2M $345M -$2.22M $5.30 138
2021 Q2 65.5M $377M -$10.7M $5.75 137
2021 Q1 67.7M $312M +$10.8M $4.61 130
2020 Q4 66.6M $222M -$12.7M $3.34 131
2020 Q3 67.9M $202M +$603K $2.97 141
2020 Q2 64.7M $299M -$2.97M $4.62 139
2020 Q1 65.8M $254M +$11.6M $3.85 128
2019 Q4 62.8M $236M -$30.8M $3.75 128
2019 Q3 61.6M $327M +$8.13M $5.31 117
2019 Q2 61.6M $236M -$4.76M $3.84 100
2019 Q1 61.5M $314M +$64.7M $5.10 88
2018 Q4 49.1M $94.3M -$21.9M $1.92 85
2018 Q3 51M $193M -$11.3M $3.78 96
2018 Q2 54.1M $169M +$2.61M $3.12 97
2018 Q1 54.7M $131M -$11.1M $2.39 98
2017 Q4 56.1M $219M +$80.4M $3.91 106
2017 Q3 35.6M $89.7M +$4.37M $2.52 78
2017 Q2 33.9M $93.7M +$24.7M $2.76 69
2017 Q1 25.3M $49.3M +$4.79M $1.95 52
2016 Q4 23.8M $25M +$513K $1.05 51
2016 Q3 23.3M $25.4M -$1.71M $1.09 46
2016 Q2 25.4M $18M -$12.3M $0.71 57
2016 Q1 37M $43.2M -$16.5M $1.17 72
2015 Q4 42.4M $104M -$6.42M $2.45 86
2015 Q3 44.7M $134M +$3.44M $3.00 88
2015 Q2 43.5M $180M +$18.7M $4.13 86
2015 Q1 38.8M $168M +$54.5M $4.33 65
2014 Q4 27.3M $81M +$8.11M $2.97 49
2014 Q3 23.6M $78.3M +$8.33M $3.32 52
2014 Q2 22.3M $56.4M +$30M $2.53 47
2014 Q1 10.3M $23.4M +$2.79M $2.26 37